Medicare Enrolled

Dr. Christopher Sheppard, MD

Internal Medicine · Uniontown, OH
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
3838 MASSILLON RD, Uniontown, OH 44685
3308969625
In practice since 2006 (19 years)
NPI: 1306924964 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sheppard from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sheppard? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sheppard

Dr. Christopher Sheppard is an internal medicine specialist in Uniontown, OH, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sheppard performed 14,051 Medicare services across 132 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sheppard received a total of $354,186 from 36 pharmaceutical and/or device companies across 1168 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sheppard is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 0% volume in OH $354,186 industry payments

Medicare Practice Summary

Medicare Utilization ↗
14,051
Medicare services
Top 0% in OH for internal medicine
132
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~740 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Ocrelizumab infusion (Ocrevus) for MS 13,800 $44 $162
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
90 $19 $130
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
72 $82 $239
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
31 $84 $600
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
29 $10 $68
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
29 $4 $20
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
98.4% high complexity
1.1% medium
0.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$354,186
Total received (2018-2024)
Avg $50,598/year across 7 years
Top 0% in OH for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
1,168
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$337,211 (95.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,084 (2.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,891 (2.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,142
2023
$2,626
2022
$2,211
2021
$28,194
2020
$27,825
2019
$109,926
2018
$181,262

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$345
Novartis Pharmaceuticals Corporation
$322
Genentech USA, Inc.
$288
Celgene Corporation
$203
GENZYME CORPORATION
$177
Biogen, Inc.
$169
TG Therapeutics, Inc.
$159
Mallinckrodt Hospital Products Inc.
$130
Alexion Pharmaceuticals, Inc.
$68
Genentech, Inc.
$61
Acorda Therapeutics, Inc
$38
Axsome Therapeutics, Inc.
$35
Sandoz Inc.
$34
ANI Pharmaceuticals, Inc.
$31
Otsuka America Pharmaceutical, Inc.
$30
Cycle Pharmaceuticals Inc
$21
Mylan Specialty L.P.
$16
Amgen Inc.
$14
Top 3 companies account for 44.6% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$199,877
Genentech USA, Inc.
$38,513
Biogen, Inc.
$26,719
EMD Serono, Inc.
$22,494
Novartis Pharmaceuticals Corporation
$18,532
Celgene Corporation
$13,144
Mallinckrodt Enterprises LLC
$7,071
E.R. Squibb & Sons, L.L.C.
$6,755
Teva Pharmaceuticals USA, Inc.
$5,927
Acorda Therapeutics, Inc
$4,658
Mallinckrodt LLC
$4,139
Mallinckrodt Hospital Products Inc.
$2,442
Alexion Pharmaceuticals, Inc.
$1,309
Banner Life Sciences, LLC
$837
TG THERAPEUTICS, INC.
$247
Avanir Pharmaceuticals, Inc.
$192
TG Therapeutics, Inc.
$184
Janssen Pharmaceuticals, Inc
$177
Genentech, Inc.
$148
SANOFI-AVENTIS U.S. LLC
$122
Otsuka America Pharmaceutical, Inc.
$82
BANNER LIFE SCIENCES, LLC
$80
Horizon Therapeutics plc
$80
Axsome Therapeutics, Inc.
$74
Exeltis, USA Inc.
$56
Bayer HealthCare Pharmaceuticals Inc.
$53
Mylan Pharmaceuticals Inc.
$51
ANI Pharmaceuticals, Inc.
$49
Mylan Specialty L.P.
$36
Sandoz Inc.
$34
Validus Pharmaceuticals LLC
$22
Cycle Pharmaceuticals Inc
$21
Allergan Inc.
$19
JAZZ PHARMACEUTICALS INC.
$16
Amgen Inc.
$14
Almatica Pharma LLC
$12
Top 3 companies account for 74.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMPYRA · AUBAGIO · AVONEX · BAFIERTAM · BRIUMVI · Bafiertam · Betaseron · COPAXONE · DISEASE STATE · Enspryng · Equetro · GILENYA · GLATIRAMER ACETATE · Glatiramer Acetate · KESIMPTA · LEMTRADA · MAVENCLAD · MAYZENT · Mavenclad · NAPRELAN · NUEDEXTA · Nuedexta · OCREVUS · Ocrevus · Ozanimod · PURIFIED CORTROPHIN GEL · Ponvory · Rebif · SOLIRIS · SUNOSI · Soliris · Sunosi · TECFIDERA · TYSABRI · Tascenso ODT · ULTOMIRIS · UPLIZNA · VRAYLAR · VUMERITY · ZEPOSIA · ZINBRYTA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for internal medicine in OH.

Looking for an internal medicine specialist in Uniontown?
Compare internal medicine physicians in the Uniontown area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
490
Per 100K population
91.1
County median income
$71,016
Nearest hospital
SUNRISE VISTA HEALTH AND WELLNESS
8.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sheppard is a mixed practice specialist, with above-average Medicare volume (top 0% in OH), with speaking/promotional industry engagement in the top 0% of OH peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sheppard experienced with ocrelizumab infusion (ocrevus) for ms?
Based on Medicare claims data, Dr. Sheppard performed 13,800 ocrelizumab infusion (ocrevus) for ms services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sheppard receive payments from pharmaceutical companies?
Yes. Dr. Sheppard received a total of $354,186 from 36 companies across 1,168 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sheppard's costs compare to other internal medicine physicians in Uniontown?
Dr. Sheppard's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sheppard) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →